Aloprim
- Product NDC
- 67457-978
- 11-digit product format
- 674570978
- Labeler code
- 67457
- Product ID
- 67457-978_4045f732-add9-4445-b4c8-a3a7f32bab46
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Allopurinol
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Mylan Institutional LLC
- Application
- NDA020298
- Marketing category
- NDA
- Marketing start
- 2020-11-18
- Marketing end
- 0000-00-00
- Substance
- ALLOPURINOL SODIUM
- Active strength
- 500 mg/25mL
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67457-978 | ALOPRIM (ALLOPURINOL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MYLAN INSTITUTIONAL LLC] | 4 | Legacy NDC | 20241004_018525b1-e37d-4ff2-9dc3-36b3d90ac3e0.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-978-50 | 67457097850 | 1 VIAL, GLASS in 1 CARTON (67457-978-50) > 25 mL in 1 VIAL, GLASS | 2020-11-18 | 0000-00-00 | No | No | Current |